소개
This skill integrates the Open Targets Platform into the Claude workflow, enabling systematic identification and prioritization of potential therapeutic drug targets. By leveraging a comprehensive GraphQL interface, users can query high-quality datasets covering human genetics, omics, literature, and clinical data to build evidence-based associations. It is an essential tool for researchers and developers needing to assess target druggability, explore safety liabilities, and conduct competitive intelligence within the drug development landscape directly through AI-guided analysis.